Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and Distal Cholangiocarcinoma: a National Population-Based Comparative Cohort Study.

J Gastrointest Surg · 2023 · PMC10073049 · PMID 36749556

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

did not reach statistical significancep = 0.068so close (0.05 < p ≤ 0.1)

On adjusted analyses, although there was a trend towards higher benefits of NAC, this did not reach statistical significance, compared with AC at a multivariable model ( HR 1.19 (0.99–1.45, p = 0.068) (Supplementary Table 3 ). hCCA Overall Survival Among patients with hCCA, the OS was 25.6 months ( CI 95% 24.0–28.0 months) and 5-year survival 26% (Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.